Benzinga | Aug 9, 2021 08:25AM EDT

Avadel Pharmaceuticals Q2 EPS $(0.33) Misses $(0.31) Estimate

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 175 percent decrease over losses of $(0.12) per share from the same period last year.